Lisak R P
Hosp Pract (Off Ed). 1983 Mar;18(3):101-9. doi: 10.1080/21548331.1983.11702495.
Myasthenia gravis is an autoimmune disease of known cause: an antibody to a specific molecule of defined structure. As long as the abnormality leading to the antibody response remains elusive, however, so will ideal treatment. In the meantime, most patients given proper management can lead normal or near-normal lives; prognosis is surprisingly good, and mortality should approach zero.
针对特定结构分子产生抗体。然而，只要引发抗体反应的异常情况仍不明确，理想的治疗方法也将难以找到。与此同时，大多数得到妥善管理的患者能够过上正常或接近正常的生活；预后出奇地好，死亡率应接近零。
